Immunodulator Effects of Interferon Therapy on Incidence of Cirrhosis and Hepatocellular Carcinoma in Patients with Chronic Hepatitis C

被引：0
|
作者：
Kutala, Blaise [1 ,2 ]
Boyer, Nathalie [3 ]
Marchand, Corinne Castelnau [1 ]
Guigui, Nathalie Giuily [4 ]
Sitruk, Veronique [1 ]
Asselah, Tarik [5 ]
Marcellin, Patrick [6 ,7 ]
机构：
[1] Beaujon Hosp, AP HP, Hepatol, Clichy, France
[2] Univ Paris, Inserm 1149, Paris, France
[3] AP HP Beaujon, Hepatogastroenterol, Clichy, France
[4] Beaujon Hosp, Clichy, France
[5] Hop Beaujon, Dept Hepatol, Clichy, France
[6] Hop Beaujon, AP HP, Serv Hepatol, Clichy, France
[7] Univ Paris Diderot, INSERM, Paris, France
来源：
HEPATOLOGY | 2018年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
686
引用
收藏
页码：407A / 408A
页数：2
相关论文
共 50 条
  • [41] Effect of the dose and duration of interferon-alpha therapy on the incidence of hepatocellular carcinoma in noncirrhotic patients with a nonsustained response to interferon for chronic hepatitis C
    Toyoda, H
    Kumada, T
    Nakano, S
    Takeda, I
    Sugiyama, K
    Kiriyama, S
    Sone, Y
    Tanikawa, M
    Hisanaga, Y
    Hayashi, K
    Honda, T
    ONCOLOGY, 2001, 61 (02) : 134 - 142
  • [42] High incidence of hepatocellular carcinoma following successful interferon-free antiviral therapy for hepatitis C associated cirrhosis
    Cardoso, Helder
    Vale, Ana
    Rodrigues, Susana
    Goncalves, Regina
    Albuquerque, Andreia
    Pereira, Pedro N.
    Lopes, Susana
    Silva, Marco
    Andrade, Patricia
    Morais, Rui
    Coelho, Rosa
    Macedo, Guilherme
    HEPATOLOGY, 2016, 64 : 663A - 663A
  • [43] High incidence of hepatocellular carcinoma following successful interferon-free antiviral therapy for hepatitis C associated cirrhosis
    Cardoso, Helder
    Vale, Ana Maria
    Rodrigues, Susana
    Goncalves, Regina
    Albuquerque, Andreia
    Pereira, Pedro
    Lopes, Susana
    Silva, Marco
    Andrade, Patricia
    Morais, Rui
    Coelho, Rosa
    Macedo, Guilherme
    JOURNAL OF HEPATOLOGY, 2016, 65 (05) : 1070 - 1071
  • [44] Impact of diabetes mellitus on incidence of hepatocellular carcinoma in chronic hepatitis C patients treated with interferon-based antiviral therapy
    Hung, Chao-Hung
    Lee, Chuan-Mo
    Wang, Jing-Houng
    Hu, Tsung-Hui
    Chen, Chien-Hung
    Lin, Chih-Yun
    Lu, Sheng-Nan
    INTERNATIONAL JOURNAL OF CANCER, 2011, 128 (10) : 2344 - 2352
  • [45] INTERFERON AND RISK OF HEPATOCELLULAR CARCINOMA IN HEPATITIS C RELATED CIRRHOSIS
    Kimer, Nina
    Gluud, Lise L.
    Dahl, Emilie K.
    Krag, Aleksander
    HEPATOLOGY, 2011, 54 : 1272A - 1272A
  • [46] Hepatocellular carcinoma development in sustained viral responders to interferon therapy in patients with chronic hepatitis C
    Enokimura, N
    Shiraki, K
    Kawakita, T
    Saitou, Y
    Inoue, H
    Okano, H
    Yamamoto, N
    Deguchi, M
    Sakai, T
    Ohmori, S
    Fujikawa, K
    Murata, K
    Niki, Y
    Nakano, T
    ANTICANCER RESEARCH, 2003, 23 (1B) : 593 - 596
  • [47] Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis C
    Kasahara, A
    Hayashi, N
    Mochizuki, K
    Takayanagi, M
    Yoshioka, K
    Kakumu, S
    Iijima, A
    Urushihara, A
    Kiyosawa, K
    Okuda, M
    Hino, K
    Okita, K
    HEPATOLOGY, 1998, 27 (05) : 1394 - 1402
  • [48] Efficacy of interferon-based antiviral therapy on the risk of hepatocellular carcinoma of patients with chronic hepatitis C: Further evidence in decompensation cirrhosis
    Ji, Fanpu
    Zhang, Shu
    Deng, Hong
    Li, Zongfang
    JOURNAL OF HEPATOLOGY, 2013, 58 (06) : 1262 - 1264
  • [49] Can interferon alfa treatment prevent hepatocellular carcinoma in patients with chronic hepatitis C infection and compensated cirrhosis?
    Harper, SE
    Dienstag, JL
    HEPATOLOGY, 1996, 23 (04) : 930 - 933
  • [50] PREVENTION BY INTERFERON-ALPHA OF HEPATOCELLULAR-CARCINOMA IN PATIENTS WITH CHRONIC ACTIVE HEPATITIS-C WITH CIRRHOSIS
    NISHIGUCHI, S
    KUROKI, T
    NAKATANI, S
    TAKEDA, T
    NAKAJIMA, S
    SHIOMI, S
    KOBAYASHI, K
    OTANI, S
    GASTROENTEROLOGY, 1995, 108 (04) : A1134 - A1134
12345